Palogic Value Management, L.P. Bristol Myers Squibb CO Transaction History
Palogic Value Management, L.P.
- $245 Billion
- Q2 2025
A detailed history of Palogic Value Management, L.P. transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Palogic Value Management, L.P. holds 33,415 shares of BMY stock, worth $1.5 Million. This represents 0.63% of its overall portfolio holdings.
Number of Shares
33,415
Previous 33,290
0.38%
Holding current value
$1.5 Million
Previous $2.03 Billion
23.82%
% of portfolio
0.63%
Previous 0.9%
Shares
14 transactions
Others Institutions Holding BMY
# of Institutions
2,706Shares Held
1.58BCall Options Held
25.9MPut Options Held
24.2M-
Vanguard Group Inc Valley Forge, PA191MShares$8.58 Billion0.22% of portfolio
-
Black Rock Inc. New York, NY159MShares$7.11 Billion0.15% of portfolio
-
Jpmorgan Chase & CO New York, NY108MShares$4.84 Billion0.52% of portfolio
-
State Street Corp Boston, MA94.8MShares$4.25 Billion0.24% of portfolio
-
Capital International Investors Los Angeles, CA66.5MShares$2.98 Billion0.83% of portfolio
About BRISTOL MYERS SQUIBB CO
- Ticker BMY
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 2,126,160,000
- Market Cap $95.3B
- Description
- Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...